Trial Profile
A Single-Arm, Multicenter Phase IIa Study Of rhLTα-Da In Combination With Cisplatin And Fluorouracil As A First-Line Therapy For The Treatment Of Patients With Metastatic Oesophageal Squamous Cell Carcinoma Or Gastric Adenocarcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 May 2017
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Fluorouracil (Primary) ; Lymphotoxin alpha (Primary)
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer; Squamous cell cancer
- Focus Adverse reactions
- 16 May 2017 New trial record